Letter ·
NAMD Comments on Office of National Drug Control Policy’s (ONDCP) 2026 Strategy
On June 20, NAMD formally commented on the Office of National Drug Control Policy’s (ONDCP) 2026 National Drug Control Strategy.
Author
- NAMD Staff
Focus Areas
Program Stream
In June 2025, NAMD submitted comments to the Office of National Drug Control Policy (ONDCP) on the development of its 2026 National Drug Control Strategy. NAMD recommends to prioritize Medicaid’s role in addressing substance use disorder (SUD) by supporting the SUD and mental health workforce, enhancing cross-system collaboration, expanding access to treatment during reentry from incarceration, and streamlining federal processes for innovation.
Read NAMD’s full comments here.
Related resources
Building a Successful Medicaid-Public Health Partnership: Lessons from New Hampshire
Published Findings: How Medicaid Addresses Member Mental Health and Substance Use Disorder Challenges
Stay Informed
Drop us your email and we’ll keep you up-to-date on Medicaid issues.